Breast Cancer : the Journal of the Japanese Breast Cancer Society
Overview
Breast Cancer: The Journal of the Japanese Breast Cancer Society is a reputable scientific journal dedicated to advancing knowledge and understanding of breast cancer. It publishes high-quality research articles, reviews, and case studies, covering various aspects of breast cancer, including prevention, diagnosis, treatment, and survivorship. With a focus on the Japanese perspective, this journal serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in breast cancer care and research.
Details
Details
Metrics
Metrics
h-index / Ranks: 5503
66
SJR / Ranks: 3463
1054
CiteScore / Ranks: 4260
5.60
JIF / Ranks: 2264
4.0
Recent Articles
21.
Nagahashi M, Ishikawa E, Nagai T, Kanaoka H, Oshiro A, Togashi Y, et al.
Breast Cancer
. 2025 Jan;
32(2):404-415.
PMID: 39808396
Purpose: The aim of this study was to examine the clinical utility of tumor-infiltrating lymphocytes (TILs) evaluated by "average" and "hot-spot" methods in breast cancer patients. Methods: We examined 367...
22.
Iwabuchi E, Miki Y, Xu J, Kanai A, Ishida T, Suzuki T
Breast Cancer
. 2025 Jan;
32(2):393-403.
PMID: 39808395
Exosome markers, CD63 and CD81, belong to the tetraspanin family and are expressed in solid tumors. It has been reported that these tetraspanin family members are prognostic factors in some...
23.
Nakamura A, Ohnuki K, Takahashi H, Usami S, Ishida Y, Shibata S, et al.
Breast Cancer
. 2025 Jan;
32(2):385-392.
PMID: 39751707
Background: The accuracy of mammography in breast cancer screening is influenced by different factors such as breast composition. However, previous studies did not evaluate the impact of breast size on...
24.
Ushigusa T, Hirakawa N, Kajiura Y, Yoshida A, Yamauchi H, Kanomata N
Breast Cancer
. 2024 Dec;
32(2):357-368.
PMID: 39729292
Background: Triple-negative breast cancer (TNBC) is a serious disease with limited treatment options. We explored the significance of androgen receptor (AR) expression and tumor-infiltrating lymphocytes (TILs) in predicting neoadjuvant chemotherapy...
25.
Liu P, Liu D, Zhao C, Wei Y, Liu X, Cui H, et al.
Breast Cancer
. 2024 Dec;
32(2):369-384.
PMID: 39729291
Background: In patients with breast cancer staged ypN1 after neoadjuvant chemotherapy (NAC), there is limited evidence-based guidance regarding exemption from axillary lymph node dissection (ALND). Methods: This study analyzed ypN1...
26.
Park Y, Jang S, Shin J, Nam C, Park E, Jang S
Breast Cancer
. 2024 Dec;
32(2):337-346.
PMID: 39699835
Background: Although the demand for care immediately after mastectomy is rising, and such medical services are referred to as post-acute care (PAC), there is limited evidence on the factors influencing...
27.
Kakumoto A, Jamiyan T, Koyanagi A, Kuroda H, Yamaguchi R, Tsuda H, et al.
Breast Cancer
. 2024 Dec;
32(2):347-356.
PMID: 39695043
Aim: To establish the histological categorization of tumor‑associated stroma (TAS) that reflects the biological behavior of triple-negative breast cancer (TNBC). Methods And Results: One-hundred-and-twenty surgically resected cases of TNBC were...
28.
Batool Z, Kamal M, Shen B
Breast Cancer
. 2024 Dec;
32(2):258-277.
PMID: 39688807
Purpose: Understanding individuals at high risk of breast cancer, as well as patients and survivors, underscores the critical role of genetic counseling in the diagnosis and treatment of breast cancer....
29.
Hattori M
Breast Cancer
. 2024 Dec;
32(1):26-32.
PMID: 39656381
Circulating tumor cells (CTCs) are tumor cells that shed from the primary tumor or metastatic loci, intravasate, and circulate in the bloodstream. CTCs have been suggested to play a major...
30.
Gamba G, Colonetti T, Uggioni M, Elibio L, Balbinot E, Heinzen R, et al.
Breast Cancer
. 2024 Dec;
32(2):242-257.
PMID: 39652259
Background: The gastrointestinal microbiota can modulate systemic estrogens, potentially influencing estrogen-induced breast neoplasia development. This study aimed to assess alterations in the gut microbiota in breast cancer patients. Methods: A...